drugset / Trial / NCT06012578
Study Evaluating ISM5411 Administered Orally to Healthy Volunteers
RandomizedSequentialDouble-blindTreatment
Summary
The goal of this clinical trial is to learn about ISM5411 in healthy subjects. The primary objective is to evaluate the safety and tolerability of single and multiple oral doses of ISM5411 in healthy subjects.
Timeline
- Start
- 2023-11-08
- Primary completion
- 2024-09-04
- Completion
- 2024-09-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ISM5411 | Small molecule | — | Oral |
Indications
No indication recorded.